Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-120
SponsorOregon Health and Science University
About this trial
This study aims to use mass spectrometry techniques to analyze exhaled patient breath in non-COVID ICU-admitted patients requiring ventilation for a rapid and accurate early detection of pulmonary diseases and inflammatory markers.
Eligibility criteria
Qualifiers
Non-COVID-19 adult consented patients (>18yo) on ventilatory support in the ICU at OHSU
Disqualifiers
Patients with "severe respiratory distress" as defined by arterial pO2 of <60 mmHg on maximal FiO2 & optimal ventilator settings
Patient with severe hemodynamic instability as defined by (a) receiving IV infusion of 2 or more pressors or inotropic medications (Levophed, vasopressin, phenylephrine, or epinephrine) & (b) MAP of <60 mmHg or SB <80 mmHg
Trial design
Treatments tested in this trial
- There is no intervention in this observational study
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov